Phenethyl Isothiocyanate Enhances the Cytotoxic Effects of PARP Inhibitors in High-Grade Serous Ovarian Cancer Cells

While PARP inhibitor (PARPi) therapies have shown promising results in the treatment of high-grade serous ovarian cancer (HGSOC) harboring homologous recombination deficiencies, primary resistance to PARPi frequently occurs and even initial responders may eventually become resistant. Therefore, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Yaxun, Wang, Min, Sang, Xiaolin, Liu, Pixu, Gao, Jingchun, Jiang, Kui, Cheng, Hailing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825372/
https://www.ncbi.nlm.nih.gov/pubmed/35155204
http://dx.doi.org/10.3389/fonc.2021.812264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825372/
https://www.ncbi.nlm.nih.gov/pubmed/35155204
http://dx.doi.org/10.3389/fonc.2021.812264

Ejemplares similares